Sarcoidosis (Q54152750)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Sarcoidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Robert P Baughman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

Elyse E Lower

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

Roland M du Bois

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

volume

361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

issue

9363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1111-1118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

Epidemiology of sarcoidosis in the Isle of Man--2: Evidence for space-time clustering

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Epidemiology of sarcoidosis in the Isle of Man--1: A case controlled study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Seasonal occurrence of sarcoidosis in Greece

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Sarcoidosis in nurses: is there an association?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The influence of diagnostic access bias on the epidemiology of sarcoidosis: A population-based study in Rochester, Minnesota, 1935–1984

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Epidemiology of sarcoidosis in the U.S. Navy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Investigation of a unique time-space cluster of sarcoidosis in firefighters

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The incidence, prevalence, and severity of sarcoidosis in New York City firefighters

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

A transmissible agent from sarcoid tissue

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Absence of DNA from Mycobacteria of theM. tuberculosis Complex in Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Familial risk ratio of sarcoidosis in African-American sibs and parents

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Epidemiology of familial sarcoidosis in the UK

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Familial sarcoidosis is linked to the major histocompatibility complex region

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

HLA and sarcoidosis in the Japanese

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

T-cell receptor variable region gene usage by CD4 and CD8 T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

HLA-DR Predicts the Prognosis in Scandinavian Patients with Pulmonary Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Case-control association studies for the genetics of complex respiratory diseases

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Analysis of HLA-DM polymorphisms in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Polymorphism in the Angiotensin-Converting Enzyme (ACE) Gene and Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Löfgren's syndrome revisited: a study of 186 patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Th1/Th2 cell distribution in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Hodgkin's disease with a granulomatous pulmonary presentation mimicking sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Nodular sarcoidosis of the liver and spleen: analysis of 32 cases

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Excessive thoracic computed tomographic scanning in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Subpleural micronodules in diffuse infiltrative lung diseases: evaluation with thin-section CT scans

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Central nervous system sarcoidosis--diagnosis and management

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Clinical characteristics of patients in a case control study of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Outcome of the treatment for sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Corticosteroid therapy in pulmonary sarcoidosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

A Controlled Trial of Prednisone Treatment of Sarcoidosis1

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Pulmonary Sarcoidosis: A Prospective Evaluation of Glucocorticoid Therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Early treatment of stage II sarcoidosis improves 5-year pulmonary function

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Ocular toxicity and hydroxychloroquine: guidelines for screening

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Prolonged use of methotrexate for sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

A clinical approach to the use of methotrexate for sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Low-dose methotrexate therapy for childhood sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Pentoxifylline in treatment of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Thalidomide for chronic sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)12888-7

7 January 2021

10.1016/S0140-6736(03)12888-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672326 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference